🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

311 results for “International” Clear

  1. Phase 1, Randomized, Double-blind, Placebo-Controlled, First-in-Human Single Ascending Dose Study in Healthy Participants to Assess the Safety, Tolerability, and Pharmacokinetics of JNJ-95597528 and a Proof of Mechanism Study in Participants with Mild to Moderate Asthma

    Janssen-Cilag International N.V.

    Mild to Moderate Asthma

    phase 1 other active

    1 trial

  2. Phase 1/2 Study of Erdafitinib Intravesical Delivery System (TAR-210) in Participants with Non-Muscle-Invasive or Muscle-Invasive Bladder Cancer

    Janssen-Cilag International N.V.

    Localized Bladder Cancer

    phase 1 other active

    1 trial

  3. Placebo

    Mirum Pharmaceuticals International B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  4. Recombinant human arginase 1 Peg5000

    International Peace Maternity and Child Health Hospital

    Leukemia

    phase 1 small molecule terminated

    1 trial

  5. Study of JNJ-74856665 in patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Janssen-Cilag International N.V.

    Acute myeloid leukemia or Myelodysplastic syndrome

    phase 1 other active

    1 trial

  6. Takeda Brentuximab; Molecular Imaging of Zirconium-89-labeled Brentuximab as a Tool to Investigate brentuximab biodistribution in CD30-positive Lymphoma

    Disc Medicine

    Patients with stage II-IV high risk diffuse large B-cell lymphoma, defined as international prognostic index > 2, Lymphoma

    phase 1 other active

    1 trial

  7. To assess the relative BA of a low-strength FDC tablet formulation of niraparib plus AA compared to niraparib and AA co-administered as single agents after single dose administration and to assess BE of a regular strength FDC tablet formulation of niraparib plus AA compared to niraparib and AA co-administered as single agents at steady state in men with prostate cancer

    Janssen-Cilag International N.V.

    Metastatic castration-resistant prostate cancer (mCRPC)

    phase 1 other active

    1 trial

  8. Z-1018

    Dynavax International B.V.

    Shingles

    phase 1 mab completed

    1 trial

  9. iridoid enriched mixed fruit beverage

    International Peace Maternity and Child Health Hospital

    Oxidative Stress

    phase 1 other completed

    1 trial

  10. DePuy ASR Hip System

    International Peace Maternity and Child Health Hospital

    Rheumatoid Arthritis

    approved other terminated

    1 trial

  11. Elobixibat 10mg

    International Peace Maternity and Child Health Hospital

    Chronic Constipation

    approved small molecule terminated

    1 trial

  12. Guselkumab

    Janssen Cilag International NV

    Arthritis, Psoriatic

    approved small molecule active

    3 trials

  13. Guselkumab 1 mL PFS Placebo, Guselkumab - solution for injection in pre-filled syringe - 100 mg/mL

    Janssen-Cilag International N.V.

    Psoriatic Arthritis

    approved small molecule active

    1 trial

  14. LCS® Complete™ Mobile Bearing Knee Systems

    International Peace Maternity and Child Health Hospital

    Knee Osteoarthritis

    approved other completed

    1 trial

  15. Livmarli Oral Product

    Mirum Pharmaceuticals International B.V.

    Alagille Syndrome

    approved small molecule active

    1 trial

  16. OROS hydromorphone

    Janssen Cilag International NV

    Cancer Pain

    approved small molecule completed

    1 trial

  17. Topiramate

    Janssen Cilag International NV

    Epilepsy

    approved small molecule completed

    1 trial

  18. Typhoid Vi vaccine

    International Peace Maternity and Child Health Hospital

    Typhoid

    approved mab completed

    1 trial

  19. Cy-TB test

    International Peace Maternity and Child Health Hospital

    Latent Tuberculosis

    other completed

    1 trial

  20. Evaluation of social, cultural and behavioral factors

    International Peace Maternity and Child Health Hospital

    Cardio-vascular Disease

    other completed

    1 trial

  21. External beam radiotherapy

    International Peace Maternity and Child Health Hospital

    Squamous Cell Carcinoma of the Head and Neck

    other active

    1 trial

  22. Letrozole

    International Peace Maternity and Child Health Hospital

    Letrozole

    small molecule active

    1 trial

  23. On-site radiologist

    International Peace Maternity and Child Health Hospital

    Tuberculosis

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources